UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ISCEV Standard for full-field clinical electroretinography (2015 update)

Documenta ophthalmologica, 2015-02, Vol.130 (1), p.1-12

2015

Volltextzugriff (PDF)

ISCEV standard for clinical pattern electroretinography (PERG): 2012 update

Documenta ophthalmologica, 2013-02, Vol.126 (1), p.1-7

2013

Volltextzugriff (PDF)

ISCEV standard for clinical electro-oculography (2010 update)

Documenta ophthalmologica, 2011-02, Vol.122 (1), p.1-7

2011

Volltextzugriff (PDF)

ISCEV standard for clinical pattern electroretinography-2007 update

Documenta ophthalmologica, 2007-05, Vol.114 (3), p.111-116

2007

Volltextzugriff (PDF)

25-LB: Oral APX3330 Reduces the DRSS Worsening after 24-weeks of Daily Treatment—Efficacy and Safety Results of the ZETA-1 Phase 2 Trial in Diabetic Retinopathy

Diabetes (New York, N.Y.), 2023-06, Vol.72 (Supplement_1), p.1

2023

Volltextzugriff (PDF)

Erratum to: ISCEV Standard for full-field clinical electroretinography (2015 update)

Documenta ophthalmologica, 2015-08, Vol.131 (1), p.81-83

2015

Volltextzugriff (PDF)

Enhancing Risk Assessment in Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and Structure

Translational vision science & technology, 2020-08, Vol.9 (9), p.40-40

2020

Volltextzugriff (PDF)

Anti-NOGO Antibody Neuroprotection in a Rat Model of NAION

Translational vision science & technology, 2021-12, Vol.10 (14), p.12-12

2021

Volltextzugriff (PDF)

Twelve-month natural history of dark adaptation in patients with AMD

Optometry and vision science, 2014-08, Vol.91 (8), p.925-931

2014

Volltextzugriff (PDF)

Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects?

Epilepsy research, 2010-11, Vol.92 (1), p.48-53

2010

Volltextzugriff (PDF)

Recommendations for a toxicological screening ERG procedure in laboratory animals

Documenta ophthalmologica, 2005-01, Vol.110 (1), p.57-66

2005

Volltextzugriff (PDF)

Quality-Controlled Measurement Methods for Quantification of Variations in Transcript Abundance in Whole Blood Samples from Healthy Volunteers

Clinical chemistry (Baltimore, Md.), 2007-06, Vol.53 (6), p.1030-1037

2007

Volltextzugriff (PDF)

Enhancing Risk Assessment in Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and Structure

Translational vision science & technology, 2020-08, Vol.9 (9)

2020

Volltextzugriff (PDF)

Extraction and modeling of the Oscillatory Potential: signal conditioning to obtain minimally corrupted Oscillatory Potentials

Documenta ophthalmologica, 2002-01, Vol.104 (1), p.37-55

2002

Volltextzugriff (PDF)

Is reduced ornithine-d-aminotransferase activity the cause of vigabatrin-associated visual field defects?

Epilepsy research, 2010-11, Vol.92 (1), p.48-53

2010

Volltextzugriff (PDF)

The Potential for Vigabatrin‐Induced Intramyelinic Edema in Humans

Epilepsia (Copenhagen), 2000-02, Vol.41 (2), p.148-157

2000

Volltextzugriff (PDF)

Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways

Neurology, 1996-08, Vol.47 (2), p.408-417

1996

Volltextzugriff (PDF)

The effects of age on steady-state pattern electroretinograms and visual evoked potentials

Documenta ophthalmologica, 1991-01, Vol.77 (3), p.201-211

1991

Volltextzugriff (PDF)

Hemianopic anosognosia

Neurology, 1997-07, Vol.49 (1), p.88-97

1997

Volltextzugriff (PDF)

Vigabatrin-associated retinal cone system dysfunction

Neurology, 1998-12, Vol.51 (6), p.1779-1779

Brigell, M G

1998

Volltextzugriff (PDF)

ALS defeats gabapentin: reflections on another failed treatment

Neurology, 2001-10, Vol.57 (8), p.1524-1525

2001

Volltextzugriff (PDF)

Recommendations for a toxicological screening ERG procedure in laboratory animals: Visual electrophysiology in drug development

Documenta ophthalmologica, 2005, Vol.110 (1), p.57-66

2005

Volltextzugriff (PDF)

Dipole-modeling of the visual evoked P300

Journal of psychosomatic research, 1996-07, Vol.41 (1), p.71-79

1996

Volltextzugriff (PDF)

The peripheral flicker effect: Desensitization of the luminance pathway by static and modulated light

Vision research (Oxford), 1997-09, Vol.37 (17), p.2419-2425

1997

Volltextzugriff (PDF)

Psychophysical and electroretinographic findings in X-linked juvenile retinoschisis

Archives of ophthalmology (1960), 1987-04, Vol.105 (4), p.513-516

1987

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(48)
Buchkapitel
(4)

Sprache

Englisch
(52)

Erscheinungsjahr

n.n

Thema

Humans
(33)
Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Ophthalmology
(21)
Biological And Medical Sciences
(17)
Medical Sciences
(14)
Neurosciences & Neurology
(14)
Clinical Neurology
(12)
Female
(12)
Male
(12)
Middle Aged
(12)
Adult
(11)
Aged
(9)
Electrophysiology
(8)
Electroretinogram
(8)
Electroretinography
(6)
Evoked Potentials, Visual
(6)
Evoked Potentials, Visual - Physiology
(6)
Investigative Techniques, Diagnostic Techniques
(6)
Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

ISCEV Standard for full-field clinical electroretinography (2015 update)

ISCEV standard for clinical pattern electroretinography (PERG): 2012 update

ISCEV standard for clinical electro-oculography (2010 update)

ISCEV standard for clinical pattern electroretinography-2007 update

25-LB: Oral APX3330 Reduces the DRSS Worsening after 24-weeks of Daily Treatment—Efficacy and Safety Results of the ZETA-1 Phase 2 Trial in Diabetic Retinopathy

Erratum to: ISCEV Standard for full-field clinical electroretinography (2015 update)

Enhancing Risk Assessment in Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and Structure

Anti-NOGO Antibody Neuroprotection in a Rat Model of NAION

Twelve-month natural history of dark adaptation in patients with AMD

Is reduced ornithine-δ-aminotransferase activity the cause of vigabatrin-associated visual field defects?

Recommendations for a toxicological screening ERG procedure in laboratory animals

Quality-Controlled Measurement Methods for Quantification of Variations in Transcript Abundance in Whole Blood Samples from Healthy Volunteers

Enhancing Risk Assessment in Patients with Diabetic Retinopathy by Combining Measures of Retinal Function and Structure

Extraction and modeling of the Oscillatory Potential: signal conditioning to obtain minimally corrupted Oscillatory Potentials

Is reduced ornithine-d-aminotransferase activity the cause of vigabatrin-associated visual field defects?

The Potential for Vigabatrin‐Induced Intramyelinic Edema in Humans

Positive spontaneous visual phenomena limited to the hemianopic field in lesions of central visual pathways

The effects of age on steady-state pattern electroretinograms and visual evoked potentials

Hemianopic anosognosia

Vigabatrin-associated retinal cone system dysfunction

ALS defeats gabapentin: reflections on another failed treatment

Recommendations for a toxicological screening ERG procedure in laboratory animals: Visual electrophysiology in drug development

Dipole-modeling of the visual evoked P300

The peripheral flicker effect: Desensitization of the luminance pathway by static and modulated light

Psychophysical and electroretinographic findings in X-linked juvenile retinoschisis

Suchergebnisse filtern